Haselmeier

Executive Summary

Haselmeier, a Swiss-based drug delivery device company and a brand of medmix, specializes in the design, development, and manufacturing of subcutaneous self-injection solutions. With over a century of heritage, the company offers a comprehensive portfolio of autoinjectors and injection pens, ranging from standardized platforms to fully customized devices. Operating as a full-service partner, Haselmeier supports clients from concept through market launch, with a focus on patient-centric, reliable, and sustainable solutions. The company targets the growing self-injection market, driven by the rise of biologics and home healthcare trends. As a private entity with no disclosed funding or valuation, Haselmeier maintains a stable position as a contract development and manufacturing organization (CDMO) in the injectable drug delivery space. While lacking recent public milestones, its long-standing expertise and integration within medmix provide a solid foundation for continued partnerships with pharmaceutical companies.

Upcoming Catalysts (preview)

• TBDPreferred partnership with a top-20 pharma for a blockbuster biologic60% success
• TBDLaunch of next-generation connected autoinjector platform50% success